Imidocarb dipropionate compound preparations for eperythrozoonosis for animals and preparation

Abstract

The present invention relates to a compound veterinary imidocarb dipropionate preparation applied to eperythrozoonosis and a preparation method thereof. The present invention is made from the main materials of the imidocarb dipropionate, astragalus extract, florfenicol and artesunate, which are confected with auxiliary materials, by the regular methods of weighing, stirring, mixing, checking, measuring, packing, etc. The compound preparation can be medicated by stirring, and the components and the weight percentages of the compound preparation are 5 percent to 15 percent of the imidocarb dipropionate, 2 percent to 5 percent of the astragalus extract, 3 percent to 12 percent of the florfenicol, 5 percent to 15 percent of the artesunate, 25 percent to 65 percent of beta-cyclodextrin and 10 percent to 40 percent of troxerutin. The present invention has the characteristics of low cost, stable storage, assured effect, thoroughly removing eperythrozoon, etc., and is a novel effective preparation for remedying animal eperythrozoonosis.

Description

technical field [0001] The invention relates to a preparation in the field of biotechnology and a preparation method thereof, in particular to a veterinary compound preparation of imidazolium dipropionate for eperythrozoonosis and a preparation method thereof. Background technique [0002] Eperythrozoonosis is a zoonotic disease caused by Eperythrozoon parasitizing on the surface of human and animal red blood cells, plasma and bone marrow. Porcine Eperythrozoonosis mainly causes fever, anemia, jaundice and sow abortion in piglets. The disease is often mixed with other pig diseases. It is difficult to prevent and control, and the harm is very serious, causing huge economic losses to the pig industry. However, there is no safe, efficient and environmentally friendly specific drug for the clinical treatment of the disease at present. Some drugs are commonly used in clinical practice and have better effects, but because they are used alone, drug resistance is prone to occur, su...

AI Technical Summary

Problems solved by technology

[0004] Found through literature retrieval to prior art, relevant report is very few, and Huang Shuihong etc. published " the medicine curative effect exploration of porcine eperythrozoon disease " on the 2nd period of " contemporary animal husbandry " in 2004, proposed to use to Eperythrozoon Sensitive drugs "Xuechongjing", sulfa-methoxine sodium, oxytetracycline, chlortetracycline, metronidazole and doxycycline in the treatment of Eperythrozoon disease can reduce the infection intensity of Eperythrozoon to a certain extent, However, none of them can purify the Eperythrozoon in the blood, and the existence of Eperythrozoon can still be detected after the treatment of the disease, and neither can completely remove the Eperythrozoon disease in the blood.